Fingerprint
Dive into the research topics of 'Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
the REMAP-CAP Investigators
Research output: Contribution to journal › Article › peer-review
66
Scopus
citations